The growing popularity of GLP-1 receptor agonist medications β commonly known as "fat jabs" or weight loss injections β is having an unexpected side effect: relationship strain. As more people achieve significant weight loss through drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), partners and family members are reporting complex emotional reactions to the changes.
Relationship counsellors and psychologists have noted a rise in cases where one partner's dramatic physical transformation leads to shifts in confidence, social behaviour, and relationship dynamics. While the person losing weight often reports improved self-esteem and a more active social life, their partners can sometimes feel left behind, insecure, or even resentful of the change.
GLP-1 medications work by mimicking hormones that regulate appetite and blood sugar, helping users feel full sooner and eat less. Clinical trials have shown that semaglutide can help users lose an average of 15% of their body weight, while tirzepatide has demonstrated losses of up to 20% or more in some studies. These are significant physical transformations that can occur over a period of months.
Experts caution that weight loss β whether achieved through medication, surgery, or lifestyle changes β can fundamentally alter a person's sense of identity and their place within a relationship. Therapists recommend that couples communicate openly about the emotional impact of such changes and consider joint counselling if tensions arise. The NHS in the UK has been expanding access to weight loss injections, meaning more couples are likely to face these dynamics in the coming years.
